141 related articles for article (PubMed ID: 38216885)
1. Value of blood oxygenation level-dependent magnetic resonance imaging in early evaluation of the response and prognosis of esophageal squamous cell carcinoma treated with definitive chemoradiotherapy: a preliminary study.
Zheng H; Zhang H; Zhu Y; Wei X; Liu S; Ren W
BMC Med Imaging; 2024 Jan; 24(1):18. PubMed ID: 38216885
[TBL] [Abstract][Full Text] [Related]
2. Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma.
Qiu B; Wang D; Yang H; Xie W; Liang Y; Cai P; Chen Z; Liu M; Fu J; Xie C; Liu H
Radiother Oncol; 2016 Nov; 121(2):239-245. PubMed ID: 27793445
[TBL] [Abstract][Full Text] [Related]
3. Role of intravoxel incoherent motion MRI in early assessment of the response of esophageal squamous cell carcinoma to chemoradiotherapy: A pilot study.
Zheng H; Ren W; Pan X; Zhang Q; Liu B; Liu S; He J; Zhou Z
J Magn Reson Imaging; 2018 Aug; 48(2):349-358. PubMed ID: 29297204
[TBL] [Abstract][Full Text] [Related]
4. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
[TBL] [Abstract][Full Text] [Related]
6. The prognostic effect of pretreatment 18F-FDG PET/CT metabolic parameters in locally advanced Esophageal Squamous Cell Carcinoma treated with definitive chemoradiotherapy.
Sakin A; Ozcelik M; Sahin S; Aydemir O; Aldemir MN; Iliklerden UH; Kotan MC
Surg Oncol; 2022 Aug; 43():101809. PubMed ID: 35809492
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
8. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
Sun NN; Ge XL; Liu XS; Xu LL
Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma.
Jeong H; Im HS; Bang Y; Kim YH; Kim HR; Lee HJ; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Lee JH; Ahn JY; Na HK; Ryu JS; Kang J; Kim SB; Kim JH; Park SR
Cancer Med; 2021 Mar; 10(5):1745-1758. PubMed ID: 33590710
[TBL] [Abstract][Full Text] [Related]
10. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
11. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy.
Qiu J; Yang J; Yu Y; Wang Z; Lin H; Ke D; Zheng H; Li J; Yao Q
BMC Cancer; 2023 Jun; 23(1):597. PubMed ID: 37380982
[TBL] [Abstract][Full Text] [Related]
13. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
14. Value of blood oxygenation level-dependent MRI for predicting clinical outcomes in uterine cervical cancer treated with concurrent chemoradiotherapy.
Lee J; Kim CK; Gu KW; Park W
Eur Radiol; 2019 Nov; 29(11):6256-6265. PubMed ID: 31016443
[TBL] [Abstract][Full Text] [Related]
15. Quantitative CT evaluation after two cycles of induction chemotherapy to predict prognosis of patients with locally advanced oesophageal squamous cell carcinoma before undergoing definitive chemoradiotherapy/radiotherapy.
Yan S; Shi YJ; Liu C; Li XT; Zhao B; Wei YY; Shen L; Lu ZH; Sun YS
Eur Radiol; 2023 Jan; 33(1):380-390. PubMed ID: 35927466
[TBL] [Abstract][Full Text] [Related]
16. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
[TBL] [Abstract][Full Text] [Related]
17. Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer.
Wu SX; Li XY; Xu HY; Xu QN; Luo HS; Du ZS; Huang HC; Wu ZY
Sci Rep; 2017 Dec; 7(1):16870. PubMed ID: 29203855
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Zheng J; Zhang H; Li S; Kang Z; Zheng F; Yao Q; Zhang X; Wu Z; Wang J; Fang W; Li J; Chen G; Chen Y; Chen M
BMC Cancer; 2023 Dec; 23(1):1193. PubMed ID: 38053017
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of fibroblast activation protein expressing tumor volume calculated from [
Zhao L; Pang Y; Chen S; Chen J; Li Y; Yu Y; Huang C; Sun L; Wu H; Chen H; Lin Q
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):593-601. PubMed ID: 36222855
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
Sun NN; Liu C; Ge XL; Wang J
Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
